Does INGENOL MEBUTATE Cause Product packaging quantity issue? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Product packaging quantity issue have been filed in association with INGENOL MEBUTATE. This represents 1.0% of all adverse event reports for INGENOL MEBUTATE.
29
Reports of Product packaging quantity issue with INGENOL MEBUTATE
1.0%
of all INGENOL MEBUTATE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From INGENOL MEBUTATE?
Of the 29 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INGENOL MEBUTATE. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does INGENOL MEBUTATE Cause?
Application site erythema (1,373)
Application site pain (1,012)
Application site vesicles (843)
Application site exfoliation (586)
Drug administered at inappropriate site (500)
Application site swelling (489)
Application site scab (451)
Application site dryness (365)
Incorrect drug administration duration (339)
Application site pruritus (291)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which INGENOL MEBUTATE Alternatives Have Lower Product packaging quantity issue Risk?
INGENOL MEBUTATE vs INLYTA
INGENOL MEBUTATE vs INOTERSEN
INGENOL MEBUTATE vs INOTUZUMAB OZOGAMICIN
INGENOL MEBUTATE vs INSULIN
INGENOL MEBUTATE vs INSULIN ASPART